![]() |
CiteULike | ![]() |
brianb's CiteULike | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancerby: Chia H. Ooi, Tatiana Ivanova, Jeanie Wu, Minghui Lee, Iain B. Tan, Jiong Tao, Lindsay Ward, Jun H. Koo, Veena Gopalakrishnan, Yansong Zhu, Lai L. Cheng, Julian Lee, Sun Y. Rha, Hyun C. Chung, Kumaresan Ganesan, Jimmy So, Khee C. Soo, Dennis Lim, Weng H. Chan, Wai K. Wong, David Bowtell, Khay G. Yeoh, Heike Grabsch, Alex Boussioutas, Patrick Tan
|
Reviews
[Write a review of this article]
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
AbstractAuthor Summary Gastric cancer is the second leading cause of global cancer mortality. With current treatments, less than a quarter of patients survive longer than five years after surgery. Individual gastric cancers are highly disparate in their cellular characteristics and responses to standard chemotherapeutic drugs, making gastric cancer a complex disease. Pathway based approaches, rather than single gene studies, may help to unravel this complexity. Here, we make use of a computational approach to identify connections between molecular pathways and cancer profiles. In a large scale study of more than 300 patients, we identified subgroups of gastric cancers distinguishable by their patterns of driving molecular pathways. We show that these identified subgroups are clinically relevant in predicting survival duration and may prove useful in guiding the choice of targeted therapies designed to interfere with these molecular pathways. We also identified specific gastric cancer cell lines mirroring these pathway subgroups, which should facilitate the pre-clinical assessment of responses to targeted therapies in each subgroup.
BibTeX record
RIS record